Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Carcinoma, Transitional Cell,Carcinoma, Non-Small-Cell Lung, Date of authorisation: 20/09/2017, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Melanoma,Hodgkin Disease,Carcinoma, Renal Cell,Carcinoma, Non-Small-Cell Lung, Date of authorisation: 19/06/2015, Revision: 27, Status: Authorised

Case Medical Research ◽

10.31525/cmr-962c37 ◽

2019 ◽

Author(s):

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Small Cell ◽

Hodgkin Disease ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Melanoma,Hodgkin Disease,Carcinoma, Renal Cell,Carcinoma, Non-Small-Cell Lung, Date of authorisation: 19/06/2015, Revision: 24, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39973f ◽

2019 ◽

Author(s):

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Small Cell ◽

Hodgkin Disease ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Carcinoma, Renal Cell,Peritoneal Neoplasms,Ovarian Neoplasms,Breast Neoplasms,Carcinoma, Non-Small-Cell Lung,Fallopian Tube Neoplasms, Date of authorisation: 14/01/2018, Revision: 3, Status: Authorised

Case Medical Research ◽

10.31525/cmr-4e9a82 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Ovarian Neoplasms ◽

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

Peritoneal Neoplasms ◽

European Public ◽

European Public Assessment Report ◽

Fallopian Tube Neoplasms ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Abraxane, paclitaxel, Breast Neoplasms,Pancreatic Neoplasms,Carcinoma, Non-Small-Cell Lung, Date of authorisation: 10/01/2008, Revision: 24, Status: Authorised

Case Medical Research ◽

10.31525/cmr-15997e6 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Pancreatic Neoplasms ◽

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Carcinoma, Non-Small-Cell Lung,Mesothelioma, Date of authorisation: 18/01/2016, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1b3e451 ◽

2019 ◽

Author(s):

Keyword(s):

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 20/09/2018, Status: Authorised

Case Medical Research ◽

10.31525/cmr-399726 ◽

2018 ◽

Author(s):

Keyword(s):

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Taxespira (previously Docetaxel Hospira UK Limited ), docetaxel, Stomach Neoplasms,Prostatic Neoplasms,Breast Neoplasms,Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung, Date of authorisation: 28/08/2015, Revision: 8, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-1f52484 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Stomach Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Taxotere, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 27/11/1995, Revision: 44, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ea7c28 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Lung Adenocarcinoma ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Breast Neoplasms, Date of authorisation: 22/05/2012, Revision: 12, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871e0 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Lung Adenocarcinoma ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Breast Neoplasms, Date of authorisation: 21/05/2012, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-543dab ◽

2018 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Lung Adenocarcinoma ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text